Acro Biomedical Co., Ltd. (ACBM): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$0
Year ended 2023-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $0 | -100.0% | 2025-07-18, From 2023-01-01 |
| 2022-12-31 | $518.0K | -44.8% | 2025-07-18, From 2022-01-01 |
| 2021-12-31 | $938.0K | +77.5% | 2023-07-21, From 2021-01-01 |
| 2020-12-31 | $528.6K | +191.3% | 2022-04-15, From 2020-01-01 |
| 2019-12-31 | $181.4K | n/a | 2021-04-02, From 2019-01-01 |
| No annual figure between 2018-09-30 and 2019-12-31. | |||
| 2018-09-30 | $7.18M | n/m | 2020-01-07, From 2017-10-01 |
| 2017-09-30 | $459.0K | n/a | 2018-12-28, From 2016-10-01 |